Status:
COMPLETED
PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?
Lead Sponsor:
Federal University of São Paulo
Conditions:
CIRRHOSIS
ESOPHAGEAL VARICES
Eligibility:
All Genders
18-78 years
Phase:
PHASE4
Brief Summary
This prospective randomized controlled trial will compare endoscopic band ligation (EBL) with propranolol and EBL alone in primary prophylaxis of variceal bleeding among cirrhotic patients with high-r...
Detailed Description
BACKGROUND AND AIMS Bleeding from esophagogastric varices (EV) is a major complication of portal hypertension. Beta-blockers are a well-established cornerstone of portal hypertension treatment. Band ...
Eligibility Criteria
Inclusion
- Liver cirrhosis with esophageal varices
- Age between 18 and 78 years
- Accept to participate
Exclusion
- Portal hypertension by schistosomiasis
- Contraindications for propranolol use
- Do not accept to participate
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01893541
Start Date
June 1 2008
End Date
June 1 2011
Last Update
July 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of São Paulo
São Paulo, São Paulo, Brazil, 04024-002